Metformin: do we finally have an anti-aging drug?
- PMID: 24189526
- PMCID: PMC3906334
- DOI: 10.4161/cc.26928
Metformin: do we finally have an anti-aging drug?
Abstract
Studies in mammals have demonstrated that hyperglycemia and hyperinsulinemia are important factors in aging and cancer. Inactivation of insulin/insulin-like signaling increases lifespan in nematodes, fruit flies, and mice. Life-prolonging effects of caloric restriction are in part due to reduction in IGF-1, insulin, and glucose levels. Antidiabetic biguanides such as metformin, which reduce hyperglycemia and hyperinsulinemia by decreasing insulin resistance, extend lifespan, and inhibit carcinogenesis in rodents. Will antidiabetic biguanides increase lifespan in humans?
Keywords: aging; cancer; diabetes; geroconversion; gerosuppression.
Similar articles
-
Metformin for aging and cancer prevention.Aging (Albany NY). 2010 Nov;2(11):760-74. doi: 10.18632/aging.100230. Aging (Albany NY). 2010. PMID: 21084729 Free PMC article. Review.
-
The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.Crit Rev Oncol Hematol. 2013 Sep;87(3):201-23. doi: 10.1016/j.critrevonc.2013.01.005. Epub 2013 Feb 21. Crit Rev Oncol Hematol. 2013. PMID: 23434537 Free PMC article. Review.
-
Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: antidiabetic drugs as geroprotectors and anticarcinogens.Ann N Y Acad Sci. 2005 Dec;1057:220-34. doi: 10.1196/annals.1356.017. Ann N Y Acad Sci. 2005. PMID: 16399897
-
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.Exp Gerontol. 2005 Aug-Sep;40(8-9):685-93. doi: 10.1016/j.exger.2005.07.007. Exp Gerontol. 2005. PMID: 16125352
-
[Role of the growth hormone-insulin-like growth factor-1-insulin system signaling in aging and longevity: evolutional aspect].Ross Fiziol Zh Im I M Sechenova. 2008 Sep;94(9):1092-109. Ross Fiziol Zh Im I M Sechenova. 2008. PMID: 18953996 Review. Russian.
Cited by
-
Epigenetics and aging.Sci Adv. 2016 Jul 29;2(7):e1600584. doi: 10.1126/sciadv.1600584. eCollection 2016 Jul. Sci Adv. 2016. PMID: 27482540 Free PMC article. Review.
-
Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer.Chem Sci. 2023 Jul 3;14(29):7842-7866. doi: 10.1039/d3sc01071f. eCollection 2023 Jul 26. Chem Sci. 2023. PMID: 37502330 Free PMC article.
-
Latest progress in tyrosine kinase inhibitors.Oncotarget. 2014 Mar 15;5(5):1157-61. doi: 10.18632/oncotarget.1836. Oncotarget. 2014. PMID: 24727648 Free PMC article.
-
The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations.Cells. 2022 Nov 29;11(23):3818. doi: 10.3390/cells11233818. Cells. 2022. PMID: 36497078 Free PMC article. Review.
-
How can aging be reversed? Exploring rejuvenation from a damage-based perspective.Adv Genet (Hoboken). 2020 Aug 10;1(1):e10025. doi: 10.1002/ggn2.10025. eCollection 2020 Dec. Adv Genet (Hoboken). 2020. PMID: 36619246 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous